Artelo Biosciences

La Jolla, United States

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

$11.0M raised

Mar 2026

Post-IPO Equity

Biotechnology Life Science Pharmaceutical

Top Investors

Bartosz Lipiński

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Artelo Biosciences

How much funding has Artelo Biosciences raised?

Artelo Biosciences has raised $11.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.

Who are Artelo Biosciences's investors?

Artelo Biosciences's investors include Bartosz Lipiński.

Where is Artelo Biosciences headquartered?

Artelo Biosciences is headquartered in La Jolla, United States.

What does Artelo Biosciences do?

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

What stage is Artelo Biosciences at?

Artelo Biosciences is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 27, 2026.

MLA

"Artelo Biosciences — Funding & Investors." VCBacked, March 27, 2026, https://www.vcbacked.co/company/artelo-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2026). Artelo Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/artelo-biosciences

Wikipedia (cite web)

{{cite web |title=Artelo Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/artelo-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 27, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K